JASONDEEP CHEEMA: Open Payments
NPI 1083189757 · THOUSAND OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 52 payments from 15 companies in 2025. Trend: 2023 $701 · 2024 $1,333 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 8 | $172 |
| ABBVIE INC. | 8 | $147 |
| Arcutis Biotherapeutics, Inc. | 10 | $146 |
| Medimetriks Pharmaceuticals, Inc. | 5 | $114 |
| Amgen Inc. | 4 | $91 |
| Incyte Corporation | 4 | $74 |
| GENZYME CORPORATION | 2 | $63 |
| Lilly USA, LLC | 2 | $59 |
| UCB, Inc. | 1 | $48 |
| ANI Pharmaceuticals, Inc. | 2 | $44 |
Products named: Zoryve, SKYRIZI, OTEZLA, Genadur, OPZELURA, DUPIXENT, TALTZ, Bimzelx.
Industry payments across CA — which companies pay providers there.
